Business Description
NeuroSense Therapeutics is an Israeli medical company working to develop new drugs for people living with serious brain diseases such as ALS, Alzheimer's, and Parkinson's. Its most advanced drug candidate, PrimeC, combines two existing medicines into a single oral pill and is currently being tested in late-stage clinical trials for ALS, with earlier studies completed for Alzheimer's. The company also has two earlier-stage drug candidates in development and operates across both U.S. and international markets.
